Celyad Oncology SA
XBRU:CYAD

Watchlist Manager
Celyad Oncology SA Logo
Celyad Oncology SA
XBRU:CYAD
Watchlist
Price: 0.1895 EUR
Market Cap: 8.5m EUR

Wall Street
Price Targets

CYAD Price Targets Summary
Celyad Oncology SA

There are no price targets for CYAD.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Celyad Oncology SA Competitors:
Price Targets
AMRN
Amarin Corporation PLC
23% Downside
ATRA
Atara Biotherapeutics Inc
214% Upside
SERA
Sera Prognostics Inc
47% Upside
688235
Beigene Ltd
18% Upside
COYA
Coya Therapeutics Inc
250% Upside
ARWR
Arrowhead Pharmaceuticals Inc
3% Downside
AVCT
Avacta Group PLC
33% Upside
068270
Celltrion Inc
4% Upside

Revenue
Forecast

Revenue Estimate
Celyad Oncology SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-44%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Celyad Oncology SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Net Income
Forecast

Net Income Estimate
Celyad Oncology SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-62%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CYAD's stock price target?
Not Available

CYAD doesn't have any price targets made by Wall Street professionals.

Back to Top